Navigation Links
Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer
Date:3/2/2009

National Product Launch to Include 24-oz and Convenient 4-oz Travel Size Spray Bottles

SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) today announced an agreement with Sterifide Laboratories for the distribution of PURE's silver dihydrogen citrate (SDC)-based disinfectant as OneShot Plus(TM) DD, a new technology in Sterifide Laboratories' OneShot Plus product line. OneShot Plus DD eliminates MRSA and VRE in only 2 minutes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)

Patrick Hurst, Vice President of Operations of Sterifide Laboratories, stated, "We live in a world where various types of organisms causing significant health problems have become resistant to previously effective disinfectants and antibiotics, and we are concerned about the growing threat of resistant pathogens like MRSA and VRE. Until recently, those pathogens were typically confined to hospitals and other closed environments but are now plaguing our communities."

Hurst continued, "That is why we welcomed the opportunity to partner with PURE Bioscience in order to add the SDC-based disinfectant as a powerful weapon against MRSA and VRE to our OneShot Plus line of products. We are first marketing OneShot Plus DD through direct-to-consumer channels, and we plan to launch our 24-oz spray and convenient 4-oz travel size nationwide by April along with the other products in our OneShot line. The marketing program targets both English and Spanish speaking consumers."

Michael L. Krall, President and CEO of PURE Bioscience, commented, "Sterifide will be uniquely positioned as it sells its SDC-based disinfectant through a new market channel. Sterifide's sales and marketing program should f
'/>"/>

SOURCE PURE Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
6. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
7. Mesa Laboratories Names New Vice President of Sales and Marketing
8. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. JDRF partners with Housey Pharmaceutical Research Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 1, 2014 (HealthDay News) -- Genes may interact with stress ... suggests. The genetic risk occurs in about 13 percent ... finding could help these people reduce their heart disease risk ... and stress management, the Duke University researchers said. The ... found a strong link between variations in the EBF1 gene ...
(Date:10/2/2014)... By Dennis Thompson ... -- A newborn,s risk of developing celiac disease isn,t reduced ... found in wheat called gluten to an infant,s diet help ... a pair of new studies in the Oct. 2 ... put to rest hopes that a child could avoid celiac ...
(Date:10/2/2014)... Dennis Thompson HealthDay ... Forty-two states and the District of Columbia now have a ... respiratory illness that has been infecting children since the ... with the virus have died in recent weeks, but it,s ... played in those deaths, officials said. Health officials are ...
(Date:10/1/2014)... small protein beta-amyloid is strongly associated with Alzheimer,s disease; ... this peptide is the causal agent of the onset ... such confirmation is that beta-amyloid is not harmful when ... is when it self-assembles to form the so-called amyloid ... target, beta-amyloid alone, but with multiple ones because each ...
(Date:10/1/2014)... human eye, the brain of a rat and a ... says a QUT leading robotics researcher. , Dr ... the new study uses new computer algorithms to enable ... tunnels. , "This is a very Frankenstein type of ... of a thing together because we,re taking the eyes ...
Breaking Medicine News(10 mins):Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2
... LeMond ... real-to-life road feel and performance output to ensure avid cyclists and triathletes stay in ... ... introduces the all-new Revolution bike trainer that delivers the industry,s most real-to-life ...
... ... get more exposure through free publicity and other low cost PR methods. , ... (PRWEB) July 2, 2010 -- ADPublishing.org LLC, ... guide which enables small business owners to generate their own free publicity. Online PR and ...
... ... C-rich , ... IL (PRWEB) July 2, 2010 -- There’s growing consumer awareness and concern in the U.S. ... children. This month (July 2010), European food and beverage manufacturers will be required to include ...
... routine for protection against infection when percutaneous endoscopic gastrostomy ... wall, is surgically inserted in the stomach. The new ... used today. The method, presented in the British ... 200 patients at the Karolinska University Hospital in Solna, ...
... ... Northwestern Health Sciences University to create an experienced team of chiropractic and medical professionals ... years old). , ... (PRWEB) July 2, 2010 -- University of Western States has partnered with Northwestern Health ...
... ... Templar cross architecture contains math codes that support frequency-based medicine. The idea ... paradigm that will change the face of future medicine. , ... (PRWEB) July 2, 2010 -- It usually ...
Cached Medicine News:Health News:As Real as It Gets: All-New LeMond Revolution Bike Trainer Delivers Incomparable Road Feel and Performance 2Health News:As Real as It Gets: All-New LeMond Revolution Bike Trainer Delivers Incomparable Road Feel and Performance 3Health News:Publishing and Media Distribution Firm Launches Online Public Relations Kit for Businesses Seeking Free Publicity 2Health News:Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children 2Health News:Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children 3Health News:Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children 4Health News:Simpler and cheaper antibiotic prophylaxis with insertion of nutrition catheter in the stomach 2Health News:Study Seeks Effective Treatment for Adolescent Low Back Pain 2Health News:Is Frequency the Future of Medicine or an Ancient Mystery Revealed? 2Health News:Is Frequency the Future of Medicine or an Ancient Mystery Revealed? 3Health News:Is Frequency the Future of Medicine or an Ancient Mystery Revealed? 4Health News:Is Frequency the Future of Medicine or an Ancient Mystery Revealed? 5
(Date:10/2/2014)... , Oct. 2, 2014   Mast Therapeutics, ... announced today that Edwin L. Parsley , D.O. ... and Senior Vice President.  Dr. Parsley has ... Aires Pharmaceuticals, Inc. in February 2014.  He has served ... and as Chief Medical Officer of Aires since April ...
(Date:10/2/2014)...   Intarcia Therapeutics, Inc. today announced successful ... clinical trials for ITCA 650 (exenatide, delivered continuously once ... The first trial, FREEDOM-1, was a placebo-controlled, double-blind phase ... of ITCA 650 in patients with type 2 diabetes ... significantly superior to placebo for both 40 mcg and ...
(Date:10/1/2014)...   Plexus Information Systems, Inc. (Plexus ... Systems (AIMS), announced a partnership with NextGen ... subsidiary of Quality Systems, Inc. and a leading ... Logo - http://photos.prnewswire.com/prnh/20140930/149406 ... This partnership extends the NextGen Healthcare product portfolio ...
Breaking Medicine Technology:Mast Therapeutics Announces Appointment Of Chief Medical Officer 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3
... Feb. 9, 2011 Reportlinker.com announces that ... in its catalogue: Global ... Plaque Treatment 2011 ... the responses of a comprehensive survey conducted ...
... 9, 2011 Reportlinker.com announces that a new ... Asia Pacific Markets for Orthopedic ... http://www.reportlinker.com/p0377965/Asia-Pacific-Markets-for-Orthopedic-Large-Joint-Reconstructive-Devices-2011.html In 2010, the ... Japan and South Korea were valued at over ...
Cached Medicine Technology:Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011 2Reportlinker Adds Asia Pacific Markets for Orthopedic Large Joint Reconstructive Devices 2011 2
... (ECP) is a surgical approach to glaucoma ... laser application. The ciliary body (which produces ... from the anterior or posterior segment, through ... tissues are easily and accurately identified utilizing ...
... of German Craftsmanship have produced ... the world. Ocutek® now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
Medicine Products: